UK Government supports ACMD plan to enable research with schedule 1 medicines such as psilocybin and MDMA
Despite the resurgence of research into the clinical efficacy and mechanism of action of psychedelic drugs such as such as psilocybin, LSD, DMT, and MDMA they are currently in Schedule 1 of the Misuse of Drugs regulations 2001.
